Madagascar vs Malaysia: HIV/AIDS deaths averted by antiretroviral therapy
Madagascar
2,165 deaths
in 2024
Malaysia
2,430 deaths
in 2024
Madagascar rank
55th
Malaysia rank
52nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Madagascar
- Malaysia
How they compare
Malaysia currently reports 2,430 deaths against 2,165 deaths in Madagascar, a difference of 265 deaths.
That makes Malaysia's figure about 1.1 times Madagascar's.
Across all 35 years both countries report, Malaysia has been ahead every year.
Madagascar ranks 55th and Malaysia ranks 52nd of 157 countries.
Malaysia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Madagascar | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.35 deaths | 2.35 deaths | Malaysia |
| 2000s | 14.82 deaths | 917.24 deaths | 902.42 deaths | Malaysia |
| 2010s | 196.24 deaths | 1,987 deaths | 1,791 deaths | Malaysia |
| 2020s | 1,309 deaths | 2,627 deaths | 1,318 deaths | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Madagascar or Malaysia?
- Malaysia, at 2,430 deaths against 2,165 deaths in Madagascar as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Madagascar and Malaysia?
- 265 deaths, with Malaysia ahead.
- How many years of comparable data are there for Madagascar and Malaysia?
- 35 years are reported by both, from 1990 to 2024.
- How do Madagascar and Malaysia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Madagascar ranks 55th and Malaysia ranks 52nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.